Member Info for greedo76

And 10p off the actual price. Inevitable profit taking from yesterday close on no news

AS is aware of the questions on this board, however given we are now 1 mth into H2 theres still 5 mths to go. No business updates mentioned via RNS so not sure why anyone is expecting news in the immediate future. Evidence has been sighted via the usage sheet in 4 core languages, most interestingly Spanish which is the native tongue of the entirety of APAC which AS mentioned. So, just an auld boring hold atm, not worth the daily ramping on this board.

Could be a covenant in the overdraft if it's been reduced

Gross exploitation = money in my pocket at the expense of idiots who need a holiday because they believe covid is just an inconvenience.....get it done

Mart, l hear you, and a very sound deconstruction of the ship thats rolling in the English channel. That said, FUTURE investors, will look to past performance of which communication is one. We haven't even had a "actively engaged with the German govt." per se RNS from the company. The proce is down over 40% from a month ago and while the business is capitalised til 2023 for therapeutics, if he comes back cap in hand to fund past then, or even for unforeseen events... would you invest?
Im averaging around 189p here, and feel hamstrung til the price comes back til l get out. Yes, I'm whinging but my cynicism is based on the communication abilities of the current CEO.

and in terms of patience, I have seen this since I got in here in February or so last year... so I have experienced AS and his bulls##t before.

Obtuse phrases are what we get from management in each presentation. AS is from that crowd " dont say anything then you cant be spanked when it doesn't happen "
Nearer than ever re pre CISION yes, but l was on with Virgin credit cards earlier and after 15 minutes waiting, I decided that even though I was probably closer to getting an answer, I hung up in fury.

Ebbs l think your right AS has exhausted his credibility capital as CEO considering he is letting the share price drift despite being privy to how far on the sales contracts are... If there are any.

Its been a while now since Trevor put his chair under the table. Wonder whats brewing?

Neil, l hope he gets a sales team in!!!

Been trying to break 10.50 on no news for a while today

We've also had no news on contracts, despite a few weeks passing since we were advised of "interest" in APAC. Big Al must be spread thin trying to sell these.

Whys that? ROFR? NDAs?

Well they've joined ODX in EUA with the FDA in the US

Similar to ODX... did AVCT seek FDA approval in the US or is that still a floating threat on their page? Not available yet in the US?

Julia Lopez is answering well. But l have a suspicion they'll now try to trip her

He must be a shareholder!! Bethel just got a kicking for failure to attend and setting this poor girl up.

Monks and Adventurous- 8th March 21
"Now that we have developed a robust lateral flow test architecture, we can easily insert Affimer reagents that that can be very rapidly developed for new variants if necessary, and indeed in response to any other future pandemic virus."

Inserting? Adjusting? Either way its a win for the team.

Each time there has been a dominant strain Avacta have simply adjusted their Chemistry set and caught it. Perhaps the bigger fish should start to take interest and indeed mull over a quick takeover based on our currently low share price especially with the AVA6000 in the pipe.
Fortunately we are well aware of the value of our shares and they won't go cheap.
Unless AS seriously drops the ball here we should be in receipt of a major order in the immediate term, likely next week or sooner.

That said, rationale doesn't seem to work with Avacta! Lol

while in signing off at the AGM, the co's accountants will have a word with AS and tell him to get a shift on with the delta variant results.